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Cellular senescence is a complex phenotype observed in diverse 
tissues at distinct developmental stages (He & Sharpless, 2017). In 
adults, senescence likely acts to irreversibly prevent proliferation of 
damaged cells (Chen et al., 2005; Cosme‐Blanco et al., 2007; Feldser 
& Greider, 2007). Senescent cells appear during chronological aging, 
aberrant oncogene expression, and exposure to DNA damaging 
agents (Bartkova et al., 2006; Chen, Fischer, Reagan, Yan, & Ames, 
1995). Without a universal marker, identification of senescent cells 
in tissues remains challenging. Expression of the tumor suppressor 
p16INK4a increases with age in numerous mouse and human tis‐
sues and, thus, considered a reliable marker (Krishnamurthy et al., 
2004). Exposure to ionizing radiation (IR) leads to delayed increase 
in p16INK4a expression in mice tissues and cancer‐treated patients (Le 
et al., 2010; Marcoux et al., 2013; Sanoff et al., 2014).
Senescent cells accumulate in tissues and secrete a 
range of cytokines, chemokines, and proteases known as the 
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Abstract
Some studies show eliminating senescent cells rejuvenate aged mice and attenuate 
deleterious effects of chemotherapy. Nevertheless, it remains unclear whether se‐
nescence affects immune cell function. We provide evidence that exposure of mice 
to ionizing radiation (IR) promotes the senescent‐associated secretory phenotype 
(SASP) and expression of p16INK4a in splenic cell populations. We observe splenic T 
cells exhibit a reduced proliferative response when cultured with allogenic cells in 
vitro and following viral infection in vivo. Using p16‐3MR mice that allow elimination 
of p16INK4a‐positive cells with exposure to ganciclovir, we show that impaired T‐cell 
proliferation is partially reversed, mechanistically dependent on p16INK4a expression 
and the SASP. Moreover, we found macrophages isolated from irradiated spleens to 
have a reduced phagocytosis activity in vitro, a defect also restored by the elimination 
of p16INK4a expression. Our results provide molecular insight on how senescence‐ 
inducing IR promotes loss of immune cell fitness, which suggest senolytic drugs may 
improve immune cell function in aged and patients undergoing cancer treatment.
K E Y W O R D S
ionizing radiation, p16INK4a, senescence, senescent‐associated secretory phenotype, spleen, 
T cell
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senescence‐associated secretory phenotype (SASP) (Coppe et al., 
2008; Kuilman et al., 2008). Why senescent cells accumulate in vivo 
remains unclear. One theory suggests senescence accumulates with 
a decline in immune functions with age. Several studies indicate 
senescent cell immune clearance in liver and tumorigenic tissues 
(Kang et al., 2011; Sagiv et al., 2013; Toso et al., 2014; Xue et al., 
2007). While senescent cells support wound healing, accumulation 
of senescent cells also appears to contribute to tumor growth and 
development of age‐associated diseases (Coppe, Kauser, Campisi, & 
Beausejour, 2006; Krtolica, Parrinello, Lockett, Desprez, & Campisi, 
2001; Oubaha et al., 2016). Significantly, genetic or pharmacological 
elimination of senescent cells reverses the onset of aging and asso‐
ciated pathologies in mice (Baker et al., 2016; Farr et al., 2017; Jeon 
et al., 2017; Ogrodnik et al., 2017; Schafer et al., 2017). Removing 
senescent cells reduces some side effects of chemotherapy and mit‐
igate IR‐induced premature aging in murine hematopoietic stem cells 
(Chang et al., 2016; Demaria et al., 2017).
Substantial data demonstrate the impact of aging on the im‐
mune system promotes increased susceptibility to infection 
(Haynes & Swain, 2012; Kogut, Scholz, Cancro, & Cambier, 2012; 
Liu et al., 2011; Nikolich‐Zugich, 2014). Several groups demon‐
strate aged individuals exhibit attenuated immune adaptive re‐
sponse, particularly reduced proliferation of T cells and dendritic 
cell function (You, Dong, Mann, Knight, & Yaqoob, 2014). Deletion 
of p16INK4a in T cells enhanced antigen‐specific immune response, 
which suggest senescence promotes an intrinsic defect in aged T 
cells (Liu et al., 2011). Moreover, mice lacking the expression of 
lamin A, a nuclear scaffolding protein, present an accelerated aging 
phenotype with immune deficiencies (Xin, Jiang, Kinder, Ertelt, & 
Way, 2015). In comparison, whether IR‐induced senescence has 
a long‐term impact on the immune system is less defined. A re‐
cent study showed mice irradiated (up to 4 Gy) at a young age 
failed to impair immune functions at old age (Pugh et al., 2016). Of 
note, the study compared irradiated aged mice (19 months) with 
F I G U R E  1   Exposure of mice to IR 
induces p16INK4a expression and SASP 
in the spleen. (a) Schematic of the 
experimental design. Briefly, 12‐week‐old 
p16‐3MR mice were exposed to 6.5 Gy 
total body irradiation, and 8 to 9 weeks 
later, mice were treated or not with 
GCV for 5 consecutive days to eliminate 
p16INK4a‐positive cells. (b) One day after 
the last GCV treatment, mice were 
injected i.p. with coelenterazine (CTZ), and 
14 min later, mice were sacrificed. Spleens 
were surgically removed to quantify 
the luminescence. Representative 
photographs are shown. (c) Shown is 
the average integrated photon density 
emitted from p16‐3MR mice exposed 
(+)	or	not	(−)	to	IR	and	treated	(+)	or	
not	(−)	with	GCV.	(d)	Quantification	of	
endogenous p16INK4a mRNA levels as 
determined by qPCR from full spleen 
lysates. 18S ribosomal RNAs was used 
as an internal control. (e) Expression 
levels of VEGF, IL‐6, KC, MCP‐1, IL‐1α, 
and IL‐10 from splenocyte lysates as 
detected by multiplex array. Shown is the 
median analyzed by one‐way ANOVA 
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age‐matched nonirradiated counterparts which already exhibit di‐
minished immune function.
We previously observed irradiated mice developed impaired 
lymphopoiesis in the bone marrow, an effect both cellular nonauto‐
nomous and dependent on p16INK4a (Carbonneau et al., 2012). Our 
current study sought to investigate whether IR‐induced p16INK4a 
expression interfered with immune cell function. Using a previously 
described senescence mouse model (Demaria et al., 2014), we show 
that senescence‐inducing IR impairs immune cell function in the 
splenic environment, an effect partially driven by the SASP and re‐
versible with clearance of p16INK4a‐positive senescent cells.
2  | RESULTS
2.1 | Exposure to IR induces features of senescence 
in the spleen
We previously showed that exposure to IR led to delayed (6–8 weeks) 
p16INK4a expression in distinct mice tissues, including the spleen (Le 
et al., 2010; Palacio, Krishnan, Le, Sharpless, & Beausejour, 2017). 
The cause for expression delay remains unclear but it protects mice 
against cancer progression (Palacio et al., 2017). No data currently 
demonstrate whether IR‐induced p16INK4a expression coincides with 
a senescence phenotype or/and whether it promotes adverse ef‐
fects on splenic cell function. We sought to answer an important 
question. What effect does senescence‐induced IR have on immune 
and splenic function?
To answer these questions, we first exposed mice to total body 
irradiation at a sublethal dose of 6.5 Gy, the maximum tolerated 
dose for mice to survive without requiring a bone marrow trans‐
plant (Figure 1a). Due to the delay in p16INK4 expression, we waited 
8 weeks post irradiation to allow increase in p16INK4a expression and 
restrict the time required to regain steady spleen cellularity. We 
could not detect one marker of senescence (senescence‐associated 
β‐galactosidase) in irradiated spleen tissue sections. However, we 
observed an increase in p16inK4a and SASP factors by qPCR along 
with a decrease in lamin B1 expression in macrophages (Figure S1A 
and B). Furthermore, we detected persistent DNA damage in stro‐
mal splenic cells, which did not appear in macrophages and hema‐
topoietic cells (Figure S1C and D). Of note, splenic cell counts never 
F I G U R E  2   Attrition of T‐ and B‐cell populations in the irradiated spleen. (a, b) Shown are the purity (left panels) and quantification of 
p16INK4a mRNA levels (right panels) of isolated B220+ and CD3+ cell populations as determined by flow cytometry and qPCR, respectively. 
18S ribosomal RNA was used as an internal control. (c–e) Quantification by flow cytometry of the absolute cell counts for CD3+CD4+, 
CD3+CD8+, and B220+ populations per full spleen collected from mice treated as indicated. Cell counts were determined 1 day following the 
last injection of GCV. Shown is the average ± SEM. The ρ value was determined by a one‐way ANOVA. *p < 0.05. n = 5–7 mice per group
(a) (b)
(c) (d) (e)
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completely reached levels observed prior to irradiation (Figure S2). 
We used p16‐3MR mice, in which p16INK4a‐positive cells are visu‐
alized and eliminated upon the administration of coelenterazine 
and ganciclovir (GCV), respectively (Demaria et al., 2014). Using 
luminescence reporter activity and qPCR data, we found p16INK4a 
expression increased threefold to fourfold in irradiated spleens and 
significantly reduced in mice injected with GCV (Figure 1b–d). We 
collected splenic cell lysates to measure secretion of SASP markers 
(IL‐1a, IL‐6, MCP‐1, KC, and VEGF). The marker's concentration in‐
creased following irradiation and diminished in GCV‐treated mice, 
except for IL‐1a (Figure 1e). Although the SASP typically reflects in‐
flammation, we observed a slight increase in IL‐10 secretion, a cyto‐
kine with pleiotropic immunosuppressive effects (Figure 1e).
2.2 | Attrition of CD3+ and B220+ cell populations 
in the irradiated spleen
A few days following IR, we detected substantial cell death in splenic 
T and B cells which also occurred in other cell populations to a lesser 
extent (Figures S2 and S3). A result consistent with the fact that lym‐
phocytes constitute a highly radiosensitive cell population. We asked 
whether IR induced p16INK4a in lymphocytes and whether this impacted 
their absolute number after reconstitution. We collected spleens from 
control, irradiated mice untreated/treated with GCV and dissociated at 
the single‐cell level. We isolated cell populations with magnetic columns 
(~90% purity as determined by flow cytometry) and extracted mRNA for 
qPCR analysis. We found p16INK4a gene expression elevated fourfold in 
F I G U R E  3   IR impairs T‐cell proliferation in vitro and in vivo. (a) Schematic of the experimental design. 12‐week‐old p16‐3MR mice 
were exposed to 6.5 Gy total body irradiation, and 8–9 weeks later, mice were treated or not with GCV for 5 consecutive days. On day 6 
(D6), mice were sacrificed and splenocytes were collected and labeled with CFSE. Alternatively, on day 15 (D15), mice were injected with 
the LCMV‐Arm and sacrificed 1 week later. (b, c) The proportion of CD3+ cell undergoing proliferation following an allogenic stimulus was 
determined by flow cytometry. In panel b, the proliferation of T cells was determined from gated CFSE‐CD3+ cells from p16‐3MR splenocyte 
responder cells mixed with CD‐1 stimulator splenocytes (ratio 1:2). In panel c, the proliferation of T cells was determined from gated CFSE‐
CD3+ from purified CD3+ responder cells mixed with CD‐1 stimulator splenocytes (ratio 1:2). (d) Quantification of the capability of splenic 
T cells to proliferate in vivo following the injection of mice with the LCMV‐Arm. Shown is the proportion of gp33+CD8+ T cells undergoing 
LCMV‐specific proliferation as determined by flow cytometry for the expression of the Ki67 proliferation marker. (e) Shown is the proportion 
of gp33+CD8+ T cells expressing granzyme B (Grz) as determined by flow cytometry. For all graphs, the average ± SEM is shown from n = 5–7 
mice except for panels d and e where each dot represents counts from an individual mouse. The ρ value was determined by a one‐way 
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CD3+ cells and fivefold in B220+ cells (Figure 2a,b). These levels are simi‐
lar to data from aged spleen‐derived lymphocytes (Krishnamurthy et 
al., 2004). Absolute cell counts diminished approximately 50% 8 weeks 
post‐IR for both CD3+ (CD4+ and CD8+) and B220+ cell populations 
(Figure 2c–e). While GCV injections effectively eliminated p16INK4a ex‐
pressing cells in both populations, only the CD3+CD4+ fraction exhib‐
ited cell levels observed in nonirradiated mice.
2.3 | Impaired proliferation of T cells depends 
on the irradiated splenic environment
We next explored the impact of p16INK4a expression on the prolifera‐
tive potential of irradiated splenic T cells. To address this question, 
we conducted a mixed lymphocyte reaction (MLR) with splenocytes 
from untreated or treated p16‐3MR mice (Figure 3a, left segment) 
F I G U R E  4   The irradiated splenic environment impairs T cell proliferation. (a) Schematic of the experimental design. CD3+ effector cells 
were isolated by negative selection from the spleens of p16‐3MR mice and labeled with CFSE. The splenic environment corresponds to CD3+ 
T	cell‐depleted	splenocytes	from	p16‐3MR	mice	previously	(8–9	weeks)	exposed	(+)	or	not	(−)	to	IR	and	treated	or	not	with	GCV.	Stimulator	
cells were freshly irradiated (30 Gy) allogenic splenocytes collected from a CD‐1 mouse. (b) Shown is the proportion of effector CD3+ 
cell undergoing proliferation in the presence of the indicated splenic environment following an allogenic stimulus (CD‐1 stimulator). T cell 
proliferation was determined by flow cytometry (CFSE dilution). (c) Shown is the proportion of effector CD3+ cell undergoing proliferation 
following stimulation with anti‐CD3/anti‐CD28‐coated beads in the lower well of a Transwell plate with the indicated (control or IR) splenic 
environment in the top well. (d) Quantification of the number of cell generation as determined by flow cytometry by gating for each CFSE 
dilution peak obtained from the proliferation conditions shown in panel C. (e) Shown is the proportion of CD3+ cell undergoing proliferation 
following an allogenic stimulus (CD‐1 stimulator) in the lower well of a Transwell plate with the indicated splenic environment (control or 
IR) in the top well. (f) Quantification of the number of cell generation as determined from the proliferation conditions shown in panel E. 
(g) Shown is the proportion of CD3+ cell undergoing proliferation following an allogenic stimulus (CD‐1 stimulator) in the lower well of a 
Transwell plate and the indicated splenic environment (IR or IR + GCV) in the top well. (h) Quantification of the number of cell generation as 
determined from the proliferation conditions shown in panel g. Shown is the average ± SEM from n = 5–7 mice. Data were analyzed by one‐
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and freshly irradiated allogenic splenocytes obtained from a CD‐1 
mouse. A one‐way MLR relies on the ability of “responder” cell (i.e., 
T cells within p16‐3MR splenocytes) activation by allogenic HLA 
molecules displayed by “stimulator” cells (i.e., antigen‐presenting 
cells in allogenic CD‐1 splenocytes). The one‐way MLR allowed us 
to restrict irradiated allogenic splenocytes to act as stimulators 
but not responders. Splenic T cells from p16‐3MR mice irradiated 
8–9 weeks earlier exhibit approximately 40% reduced proliferation 
compared to splenic T cells from nonirradiated mice (~65%–70% vs. 
~35%–40%, see Figure 3b). Significantly, the proliferation of splenic 
T cells was restored in irradiated mice treated with GVC (Figure 3b). 
In contrast, magnetically purified T cells (not full splenocytes) did not 
demonstrate improved proliferative capacity (Figure 3c).
To confirm this result, we measured the capacity of splenic T 
cells to proliferate in vivo in response to an acute lymphocytic chori‐
omeningitis virus Armstrong (LCMV‐Arm) infection (Figure 3a, right 
segment). Seven days post viral infection, we detected reduced pro‐
liferation in a subset (CD8+gp33+, a dominant epitope of LCMV‐Arm) 
as measured by Ki67 expression (Figure 3d). GCV injection prior 
to viral infection promoted increased proliferation of antigen‐spe‐
cific T cells. However, GCV did not significantly impact (p = 0.19) 
CD8+gp33+ T cells to secrete granzyme B in response to the LCMV‐
Arm infection (Figure 3e). At the time of sacrifice, all mice had elim‐
inated the virus showing no difference in serum (data not shown).
Overall, these results demonstrate that IR does not impair intrin‐
sic proliferation of splenic T cells. Irradiated splenocytes appear to 
compromise T‐cell proliferation in vitro and in vivo which suggests 
the splenic environment, either cells or their secretome, interferes 
with T‐cell proliferation. To test this notion, we performed a MLR 
with CD3+ effector T cells purified from p16‐3MR mice and stimu‐
lator cells from freshly irradiated CD‐1 splenocytes. We placed ef‐
fector and stimulator cells in the presence of an “environment” of 
CD3+‐depleted splenocytes isolated from p16‐3MR mice (Figure 4a). 
This experimental setup confirmed that the presence of a previously 
(8–9 weeks) irradiated splenic environment compromised the prolif‐
erative capacity of purified T cells (Figure 4b). Additionally, we par‐
tially restored T cell proliferation when we used splenic environment 
from GCV‐treated mice with GCV (Figure 4b).
To identify whether irradiated splenocytes or their secretome 
proved detrimental to T cell proliferation, we performed a modified 
MLR whereby we separated effector/stimulator cells from spleno‐
cytes using a transwell. Thus, preventing cellular interaction allowed 
us to determine whether the splenic environment (secretome) ef‐
fectively interfered with proliferation. Using beads coupled to anti‐
CD3 and anti‐CD28 antibodies as stimulator, we found that delay in 
T cell proliferation only required exposure to irradiated splenocyte 
secretome (Figure 4c,d). We confirmed the negative impact of irradi‐
ated secretome on T cell proliferation, testing allogenic splenocytes 
F I G U R E  5   Impaired macrophage and 
DC counts and function in the splenic 
environment. (a, b) Shown are the purity 
(left panels) and quantification of p16INK4a 
mRNA levels (right panels) of isolated 
F4/80+ macrophages and CD11c+ DC 
cell populations as determined by flow 
cytometry and qPCR, respectively. 18S 
ribosomal RNA used as an internal control. 
(c, d) Shown is the quantification by flow 
cytometry of the absolute cell counts 
per spleens for F4/80+ and CD11c+ cell 
populations, respectively, collected from 
mice treated as indicated. Cell counts 
were determined 1 day following the last 
injection of GCV. (e, f) Quantification 
of the proportion of purified F4/80+ 
macrophages and CD11c+ DC populations 
capable of phagocytosis. Shown is the 
average ± SEM from n = 7–15 mice per 
group except for panels e and f where 
each dot represents counts from an 
individual mouse. The ρ value was 
determined by a one‐way ANOVA. 
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collected from a CD1 mouse as stimulator. We similarly found 
proliferation of T cells diminished in the presence of an irradiated 
splenic environment (Figure 4e,f) and increased with GCV treat‐
ment (Figure 4g,h). Of note, GCV treatment greatly increased the 
proportion of cells undergoing more than one round of replication 
(Figure 4h). Taken together, these results demonstrate the splenic 
environment (through the SASP) partially impairs T cell proliferation.
2.4 | IR impairs macrophages and dendritic cells 
in the spleen
Macrophages and dendritic cells (DC) play a pivotal role in in‐
nate and adaptive immunity through their capacity to phagocyte, 
process, and present antigens. These cells exhibit more radio‐ 
resistance than lymphocytes 1 week following exposure to IR (Figure 
S2 and S3). However, 8–9 weeks after IR, these cells (herein defined 
as F4/80+ for macrophages and CD11c+ for DC) display elevated 
levels of p16INK4a expression and a decrease in absolute cell number 
compared to cells collected from nonirradiated animals (Figure 5a–d). 
In particular, macrophages display approximately 20‐fold increase in 
p16INK4a expression which GVC injection completely abrogates. In 
contrast, DC only exhibit a threefold to fourfold increase in p16INK4a 
expression which GVC only partially rescues. GVC administration re‐
stored the absolute cell count of both populations, with macrophage 
counts slightly higher (Figure 5c,d). However, phagocytes from ir‐
radiated mice exhibited reduced function as evidenced by their di‐
minished capacity to take up a fluorescent substrate. Treatment of 
mice with GVC partially rescued macrophage capacity but not DC 
(Figure 5e,f). We suspect that this defect is intrinsic to irradiated 
cells, as we used magnetically purified populations of macrophages 
and DC in this assay (purity >90%). Moreover, we did not detect a 
reduction in the number of particles taken up by each cell, as deter‐
mined by mean fluorescence (data not shown). We also observe a 
reduction in the expression of costimulatory molecules (CD80 and 
CD86) expressed on irradiated macrophages and DC compared to 
nonirradiated controls (Figure S4). Further studies are needed to 
evaluate whether such reduction is sufficient to drive impaired T cell 
proliferation. This result suggests that a sub‐population of cells lost 
their ability to phagocyte in contrast to a majority of cells with a 
slightly diminished capability.
3  | DISCUSSION
Identification of the mechanisms involved in the loss of immune cell 
fitness, either during normal aging or following exposure to chemo/
radiotherapy, is necessary for the development of a pharmacological 
treatment. Overall, we notice that exposure of mice to IR leads to a 
decrease in the counts of macrophage, dendritic and lymphoid cell 
populations in the spleen. Macrophages and DC represent a small 
proportion of myeloid cells, and these results are consistent with 
myeloid skewing we and others observed in the peripheral blood of 
irradiated mice (Carbonneau et al., 2012; Chang et al., 2016). Here, 
we provide evidence p16INK4a expression increases the presence of 
a SASP in the irradiated spleen. We show previously (8–9 weeks) ir‐
radiated mice exhibit compromise proliferation of splenic T cells in 
vitro (upon allogenic stimulation) or in vivo (in response to an acute 
LCMV‐Arm infection). Defect in T cell proliferation appeared nonau‐
tonomous as CD3+ purified cells from irradiated spleens proliferate 
as expected in a MLR assay. These results suggest that increase in 
p16INK4a expression (fourfold) is not sufficient to limit proliferation. 
Alternatively, perhaps only a small fraction of cells express higher 
level of p16INK4a (Liu et al., 2019). Unfortunately, the limitation of 
the 3MR reporter genes (intensity of the luminescence/fluorescence 
signal) prevents the quantification of p16INK4a expression at the sin‐
gle‐cell level. Despite relative purity (over 90%) of the CD3+ cell 
populations used in our studies, we cannot rule out the possibility 
that the increase originates from a few contaminating cells express‐
ing high levels of p16INK4a (such as macrophages).
We also observed that the irradiated splenic environment limits 
the proliferation of T cells in conditions with irradiated stimulator 
cells (CD‐1 mouse splenocytes). This observation stems with freshly 
irradiated CD‐1 compared to splenocytes isolated from p16‐3MR 
mice irradiated for as long as 8–9 weeks. We speculate freshly irra‐
diated CD‐1 cells require time postirradiation to develop a SASP and 
an increase p16INK4a expression, the latter delayed several weeks 
post exposure to IR (Le et al., 2010).
Our results also show that the SASP mediates part of the in‐
hibitory effect induced by the irradiated splenic environment. We 
identified several SASP factors, but unable to distinguish whether 
a specific cytokine promoting the proliferation of T cells decreased 
or the secretion of an inhibitory molecule increased. A possible 
candidate‐IL‐10, an immunosuppressive cytokine, whose expression 
increased twofold in irradiated spleens and reduced following ad‐
ministration of GCV. Intriguingly, we observed the inhibitory impact 
of irradiated splenic environment on proliferation of purified CD3+ 
T cells more pronounced (55%) than on nonpurified splenic T cells 
(40%, see Figures 4b vs. 3b, respectively). This result likely due to 
addition of a small volume of purified CD3+ T cells in the MLR mix 
only marginally dilutes the irradiated environment.
Our MLR data performed in the absence of cellular interactions 
between effector cells and the irradiated splenocyte environment 
showed a smaller decrease in T cell proliferation compared to irra‐
diated splenocytes in contact with effector cells (Figure 4e vs. b). A 
possible explanation for this difference we observed reduced phago‐
cytosis capacity in macrophages and DC, a defect only restored 
in macrophages following elimination of p16INK4a‐positive cells. 
Whether a decrease in phagocytosis is sufficient to negatively im‐
pact T cell proliferation in the context of a MLR requires more study. 
We also observe a slight increase in the number of macrophages 
following the injection of GCV in irradiated mice, an unexpected re‐
sult given the high level of p16INK4a expression in this population. 
We speculate the increase may result from peripheral macrophages 
recruited to the spleen in response to GCV‐induced cell death. 
Recent data demonstrate immune stimuli modulate the expression 
of p16INK4a in macrophages, suggesting a complex regulation in these 
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cells and more work required to delineate complex regulation (Hall 
et al., 2017).
Studies in aging mice and humans show an increase in the pro‐
portion of regulatory T cells (T regs) that impair immune function 
(Sharma, Dominguez, & Lustgarten, 2006; Simone, Zicca, & Saverino, 
2008). We quantified the proportion of T regs in the spleen and 
found their number sharply decreased in irradiated mice (with and 
without treatment with GCV), suggesting these cells are unlikely to 
negatively impact proliferation of T cells (Figure S5). Finally, IR may 
act on the stromal architecture of the spleen stroma. Indeed, we ob‐
serve a significant increase in p16INK4a expression and decrease in 
absolute cell counts following the injection of GCV in sub‐popula‐
tions (gp38+ and CD35+) of splenic stromal cells (Figure S6). Hence, 
while we show that the SASP negatively affects proliferation of 
splenic T cells, the overall impact of IR on the spleen function may 
alter multiple signaling pathways and is likely multifactorial.
In conclusion, we demonstrate that elimination of p16INK4a ex‐
pressing cells within the splenic environment improves some im‐
mune cell functions. Studies to evaluate whether newly developed 
senolytic drugs (Baar et al., 2017) also increase the fitness of im‐
mune cells in aged mice or mice receiving radiotherapy and/or che‐
motherapy may provide additional information.
4  | MATERIAL S AND METHODS
4.1 | Animals and treatments
p16‐3MR mice were kindly donated by Dr. Judith Campisi (Buck 
Institute) and breed on site according to a material transfer agree‐
ment (Demaria et al., 2014). All in vivo manipulations were approved 
by the Comité Institutionnel des Bonnes Pratiques Animales en 
Recherche of the CHU Ste‐Justine. 12‐ to 14‐week‐old p16INK4a‐
3MR mice were exposed to X‐rays at the single sublethal dose of 
6.5 Gy (1 Gy/min) using a Faxitron CP‐160. GCV was administrated 
daily by intraperitoneal (i.p.) injections for 5 consecutive days at a 
dose of 25 mg/kg in 1X‐PBS (Sigma).
4.2 | Viral infection
Mice were injected i.p. with 2 × 105 pfu of lymphocytic choriomen‐
ingitis virus (LCMV) strain Armstrong (LCMV‐Arm) to generate 
acute infection. Seven days postinfection, spleens were harvested 
from infected mice and filtered through a 70 μm pore‐size cell 
strainer (Falcon, Franklin Lakes, NJ) and centrifuged at 200 g for 
5 min at 4°C. Splenocytes were treated with NH4Cl to remove 
erythrocytes. For all experiments, dead cells were stained with 
fixable LIVE/DEAD Aqua (Catalog, L3496, Life Technologies) and 
excluded from the analysis. For granzyme B release, splenocytes 
were restimulated in vitro for 4 hr with a cognate gp33 peptide 
(0.1 mM) in the presence of GolgiStop (Catalog, 554724, BD). Cells 
were then fixed and permeabilized using the Cytofix/Cytoperm 
kit (Catalog, 554722, BD) and stained for granzyme B (Clone 
GRB05, Life Technologies). For nuclear staining, splenocytes were 
processed directly ex vivo. Cells were Fc‐blocked, and extracel‐
lular staining was performed in 50–100 μl of PBS with 2% (vol/
vol) FBS for 20 min on ice before fixation. Cells were fixed with 
Cytofix/Cytoperm (Catalog, 554722, BD) followed by intracellular 
Ki67 staining (Clone SolA15, Bioscience).
4.3 | Bioluminescence
To detect luminescence from the 3MR gene cassette, mice were 
anesthetized using isoflurane and injected i.p. with water‐soluble 
coelenterazine (CTZ; Catalog, 3031, NanoLight Technology™) at a 
concentration of 1 mg/ml in 1X‐PBS. Mice were imaged using the 
Epi‐Fluorescence & Trans‐Fluorescence Imaging System (Labeo 
Technologies) 14 min postinjection. Mice were euthanized, spleens 
surgically removed, and bioluminescence levels measured ex vivo in 
a solution of 1 mg/ml of CTZ.
4.4 | Gene expression
RNA was extracted from spleens and from isolated CD3+, B220+, 
gp38+, CD35+, CD11c+, and F4/80+ cell populations using the 
RNeasy® Mini or Micro Kit (Qiagen). Cells were purified using 
EasySep™ PE Positive Selection Kit (Catalog, 18551, StemCell 
Technologies) according to the manufacturer's instructions. RNA 
was reverse‐transcribed using the QuantiTect Reverse Transcription 
Kit. Quantitative differences in gene expression were determined 
by real‐time quantitative PCR using SensiMixTM SYBR Low‐ROX 
(Quantace) and the MxPro QPCR software (Stratagene). Values are 
presented as the ratio of target mRNA to 18S rRNA, obtained using 
the relative standard curve method of calculation.
4.5 | Flow cytometric analysis
To obtain absolute cell counts from various populations, spleens were 
processed in 1X‐PBS containing 2% FBS and mechanically disrupted 
with flat portion of a plunger from a 5 mL syringe. Samples were 
incubated with collagenase D for 30 min (Catalog, 11088866001, 
Roche). Splenic cell suspension was passed through a 70 μm pore‐
size cell strainer (Falcon, Franklin Lakes, NJ) and centrifuged at 
200 g for 5 min at 4°C. Splenic cell counts were determined using 
Count Bright® Absolute Counting Beads (Catalog, C36950, Thermo 
Fisher) and analyzed using the Becton Dickinson Immunocytometry 
Systems (BD LSR‐Fortessa™). Briefly, red blood cells were lysed by 
adding 5 ml of lyse solution (0.14 M NH4CL, 0.02 M Tris‐HCl, pH 
7.2). The tubes were incubated at room temperature (RT) for 5 min 
and washed twice with 10 ml of Roswell Park Memorial Institute 
(RPMI) medium containing 10% fetal bovine serum (FBS). Cells were 
centrifuged and pellet re‐suspended in 3 ml of 1X‐PBS from which 
10 µl of cell suspension was stained with fluorophore‐conjugated 
antibodies all purchased from BioLegend: F4/80 (clone BM8), CD3 
(clone 17A2), CD4 (clone GK1.5), CD8α (clone 53–6.7), CD11b (clone 
M1/70), CD11c (clone N418), CD35 (clone 7E9), gp38 (clone 8.1.1), 
CD31 (clone 390), PDGFR (clone APA5), and CD45 (clone 30‐F11).
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4.6 | In vitro phagocytosis assay
Splenic CD11c+ DCs and F4/80+ macrophages were purified using 
the EasySep™ PE Positive Selection Kit according to the manufac‐
turer's instructions. Purified cells (purity of ~90%) were used at a 
concentration of ~1 × 105 cells/ml in RPMI supplemented with 10% 
FBS and 1% antibiotics containing Phrodo™ Green Zymosan A parti‐
cles (Catalog, P35365, Thermo Fisher) for 90 min at 37C in a 5% CO2 
incubator. Phagocytosis of Zymosan A particle by purified CD11c+ 
DCs and F4/80+ macrophages was determined by flow cytometry 
on a minimum of 50,000 events.
4.7 | Multiplex cytokine analysis
The splenic cell secretome was quantified by Eve Technologies 
(Calgary, Canada) using the 31‐Plex Mouse Cytokine Array/
Chemokine Array. Splenocyte samples were processed according 
to Eve Technologie's recommendations. Briefly, 1 × 107 splenocytes 
were pelleted and washed twice with 1X‐PBS; then, cells were lysed 
with radioimmunoprecipitation assay (RIPA) buffer on ice for 10 min 
(20 mM Tris‐HCl, pH 7.5, 0.5% Tween‐20, 150 mM NaCl) with 1% 
protease inhibitors (PI). Lysates were centrifuged at 10,000 g for 
10 min at 4°C and supernatants transferred to a new tube and nor‐
malized with 1X‐PBS to 0.5 mg/ml of proteins.
4.8 | T cell proliferation assays
T cell proliferation was evaluated by an allogenic mixed lympho‐
cyte reaction (MLR) assay. Briefly, cells were harvested from 
spleens of p16‐3MR mice irradiated 8–9 weeks earlier and un‐
treated or treated with GCV for 5 consecutive days prior to 
sacrifice. Splenocytes or purified CD3+ cells were labeled with 
CellTrace™ 6‐carboxy‐succinimidyl‐fluorescein‐ester dye (CFSE) 
and used as responder. CD3+ cells were isolated by negative selec‐
tion using the EasySep Mouse T Cell Isolation Kit (Catalog, 19851, 
STEMCELL). The purity of CD3+ cells was determined by flow 
cytometry using a PE‐conjugated anti‐CD3 antibody (Catalog, 
100240, BioLegend). Splenocytes obtained from the outbred 
CD‐1®IGS mouse strain (Charles River) were used as stimulator 
and irradiated at a dose of 30 Gy. Mixed lymphocyte reactions 
were set up with 1 × 105 CFSE‐labeled p16‐3MR responder cells 
and 2 × 105 freshly irradiated allogenic CD‐1 stimulator spleno‐
cytes in round‐bottom 96‐well plates, at 37°C, 5% CO2 for 3 days. 
Alternatively, responder and stimulator cells were separated 
by a 8.0 µm Transwell® system (Catalog, 3422, Costar). Where 
 indicated, responders and stimulators were mixed with a splenic 
“environment” consisting of freshly isolated splenocytes depleted 
of CD3+ cells using a magnetic‐bead‐mediated positive PE selection 
kit (Catalog, 19851, STEMCELL). Depletion efficiency measured 
by flow cytometry was over 90%. Negatively isolated p16‐3MR 
CFSE‐labeled CD3+ cells were incubated in a CD3+‐depleted envi‐
ronment at a proportion of 1:5. The combination of CFSE‐labeled 
CD3+ cells and CD3+‐depleted splenocytes was incubated with 
allogenic CD‐1 splenocytes at a proportion of 1:2. Where indi‐
cated, the proliferation of p16‐3MR CFSE‐labeled CD3+ responder 
cells was also induced using the Dynabeads® mouse T‐activator 
CD3/CD28 system (11456D, Fisher).
4.9 | Statistical analysis
GraphPad Prism 7 software was used for statistical analysis; ρ values 
on multiple comparisons were calculated using one‐way analysis of 
variance (ANOVA) with Bonferroni post hoc test.
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